The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Letter to the editor

Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients

EuroIntervention 2015;11:e1-e3 - published online ahead of print September 2014. DOI: 10.4244/EIJY14M09_08

Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
We read with great interest the recent report by Capodanno et al1. In the European multicentre GHOST-EU registry, the authors reported that the rate of definite/probable scaffold thrombosis was 2.1% (definite scaffold thrombosis: 1.8%, probable scaffold thrombosis: 0.3%) in an all-comers population at six months. More specifically, the rate of definite/probable scaffold thrombosis was 1.4% (9/626) in stable/silent angina pectoris (SAP), 2.5% (14/563) in acute coronary syndrome (ACS) and 2.1% (4/192) in ST-segment elevation myocardial infarction (STEMI). This publication prompted us to review the rates of scaffold thrombosis in all-comers, SAP, ACS and STEMI either reported so far in peer review journals or presented at international ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program